We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$537M
AUM Growth
-$29.7M
Cap. Flow
-$38.7M
Cap. Flow %
-7.2%
Top 10 Hldgs %
25.68%
Holding
239
New
7
Increased
59
Reduced
137
Closed
27

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$3.89M
2
AAPL icon
Apple
AAPL
+$3.14M
3
MSFT icon
Microsoft
MSFT
+$2.91M
4
MRK icon
Merck
MRK
+$1.55M
5
ABT icon
Abbott
ABT
+$1.17M

Sector Composition

Rank Sector Weight
1 Technology 13.63%
2 Financials 12.8%
3 Healthcare 11.25%
4 Industrials 9.82%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
51
General Mills
GIS
$20.1B
$3.55M 0.66%
64,338
+518
+0.8% +$27.9K
EFV icon
52
iShares MSCI EAFE Value ETF
EFV
$27.2B
$3.33M 0.62%
70,204
+677
+1% +$31.6K
JNK icon
53
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.28B
$3.32M 0.62%
30,495
-760
-2% -$82.4K
WEC icon
54
WEC Energy
WEC
$36.7B
$3.17M 0.59%
33,389
-3,342
-9% -$301K
T icon
55
AT&T
T
$153B
$3.08M 0.57%
107,725
-43,942
-29% -$1.16M
VNQ icon
56
Vanguard Real Estate ETF
VNQ
$39.4B
$3.07M 0.57%
32,969
-9,724
-23% -$883K
GOOG icon
57
Alphabet (Google) Class C
GOOG
$4.29T
$3.03M 0.56%
49,720
-9,520
-16% -$563K
SPEM icon
58
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17B
$2.95M 0.55%
86,180
-5,363
-6% -$186K
CVS icon
59
CVS Health
CVS
$137B
$2.93M 0.55%
46,481
-5,448
-10% -$323K
GPC icon
60
Genuine Parts
GPC
$16.8B
$2.93M 0.55%
29,435
-113
-0.4% -$10.8K
MA icon
61
Mastercard
MA
$484B
$2.84M 0.53%
10,468
-3,200
-23% -$882K
DGX icon
62
Quest Diagnostics
DGX
$23B
$2.78M 0.52%
25,996
+703
+3% +$72.2K
ILMN icon
63
Illumina
ILMN
$27.9B
$2.77M 0.52%
9,368
+574
+7% +$169K
PG icon
64
Procter & Gamble
PG
$347B
$2.77M 0.52%
22,255
-718
-3% -$84.8K
NKE icon
65
Nike
NKE
$64.5B
$2.76M 0.51%
29,352
-352
-1% -$30.2K
CVX icon
66
Chevron
CVX
$378B
$2.64M 0.49%
22,263
-5,027
-18% -$611K
PFE icon
67
Pfizer
PFE
$141B
$2.56M 0.48%
75,016
-20,964
-22% -$762K
VBR icon
68
Vanguard Small-Cap Value ETF
VBR
$36.8B
$2.41M 0.45%
18,742
-5,833
-24% -$747K
SLB icon
69
SLB Ltd
SLB
$69.4B
$2.23M 0.42%
65,339
+2,398
+4% +$87.6K
D icon
70
Dominion Energy
D
$61.9B
$2.15M 0.4%
26,534
-322
-1% -$24.9K
WMT icon
71
Walmart Inc
WMT
$893B
$2.13M 0.4%
53,763
-4,068
-7% -$154K
ICE icon
72
Intercontinental Exchange
ICE
$80.1B
$2.12M 0.39%
22,988
+296
+1% +$27K
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.06T
$2.11M 0.39%
10,160
-2,609
-20% -$538K
EQIX icon
74
Equinix
EQIX
$100B
$1.98M 0.37%
3,438
-275
-7% -$148K
CTSH icon
75
Cognizant
CTSH
$21.1B
$1.98M 0.37%
32,830
+734
+2% +$46.4K

Similar funds

Girard Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Girard Partners held 239 positions worth $537M, down 5.2% from $567M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Girard Partners withdrew a net $38.7M in Q3 2019, closing 27 positions and reducing 137 holdings. Its most notable exit was iShares Russell Mid-Cap Value ETF, an estimated $1.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Girard Partners opened a new position in State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF worth $562K.

  • Girard Partners's largest Q3 2019 buy was State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF: 15,305 shares worth $562K.
  • Girard Partners added most to Comcast in Q3 2019, an estimated $1.59M increase.
  • Girard Partners's biggest Q3 2019 reduction was Visa, cutting an estimated $3.89M.
  • Girard Partners fully exited iShares Russell Mid-Cap Value ETF in Q3 2019, selling an estimated $1.03M.
  • Girard Partners's ten largest holdings make up 26% of its $537M portfolio in Q3 2019.
  • Girard Partners opened 7 new positions and closed 27 in Q3 2019.
  • Girard Partners's portfolio value fell 5.2% quarter-over-quarter to $537M.

Based on Girard Partners's 13F filing for Q3 2019, filed 1 Nov 2019.